The Booming Third Generation Sequencing Market : A Closer Look at the Rise of Nose Reshaping Procedures

Third-generation sequencing (also known as long-read sequencing) is a class of DNA sequencing methods. Third-generation sequencing works by reading nucleotide sequences at a single molecule level, which is capable of producing substantially much longer reads than the current methods. It has the ability to generate longer reads than second-generation sequencing, also known as next-generation sequencing. Moreover, third-generation sequencing has emerged as the ‘gold-standard’ technology for cDNA sequencing.

Market Dynamics:

Rising prevalence of chronic and infectious diseases, increasing applications in clinical diagnosis, growing applications of genomics, rise in focus on drug discovery and development, and growing efficiency compared to traditional technologies are major factors expected to propel growth of the global third generation sequencing market.

For instance, with the rise in burden of chronic disease, the usage or demand for third-generation sequencing technology-based devices is also increasing with a rapid pace. According to the World Health Organization (WHO), September 2022 report, non-communicable diseases (NCDs) kill 41 million individuals each year, equivalent to 74% of all deaths worldwide. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).

Moreover, according to the Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the U.S.

Key features of the study:

• This report provides in-depth analysis of the global third generation sequencing market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global third generation sequencing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Phase Genomics, Inc., GenapSys Inc., GATC Biotech AG, Stratos Genomics, Inc., Genia Technologies, Inc., Nabsys, Inc., Loop Genomics, Agilent Technologies, Inc., QIAGEN N.V., Illumina, Inc., F. Hoffmann-La Roche AG, BGI Genomics Co., Ltd., Oxford Nanopore Technologies, Ltd., Thermo Fisher Scientific Inc., and Pacific Biosciences of California, Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global third generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global third generation sequencing market.

Detailed Segmentation:

• Global Third Generation Sequencing Market, By Technology:
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Nanopore Sequencing
  • Others
• Global Third Generation Sequencing Market, By Product:
  • Instruments
  • Reagents and Consumables
  • Services
• Global Third Generation Sequencing Market, By Application:
  • Genome Sequencing
  • Epigenetics
  • Transcriptomics
  • Metagenomics
  • Others
• Global Third Generation Sequencing Market, By End user:
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Contract Research Organizations (CROs)
  • Others
• Global Third Generation Sequencing Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles:
  • Phase Genomics, Inc.
  • GATC Biotech AG
  • Stratos Genomics, Inc.
  • Genia Technologies, Inc.
  • Nabsys, Inc.
  • Loop Genomics
  • GenapSys Inc.
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • F. Hoffmann-La Roche AG
  • BGI Genomics Co., Ltd.
  • Oxford Nanopore Technologies, Ltd.
  • Pacific Biosciences of California, Inc.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights

Phone:

US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: [email protected]